Nyxoah (NYXH) Income from Non-Controlling Interests (2021 - 2024)
Nyxoah's (NYXH) quarterly Income from Non-Controlling Interests came in at $594.1 million in Q4 2024, up 1515.91% year-on-year from $36.8 million in Q1 2024, and up 1515.91% quarter-over-quarter from -$42.0 million in Q4 2023.
Nyxoah (NYXH) Income from Non-Controlling Interests (2021 - 2024) Analysis & Trends
Nyxoah's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $594.1 million for Q4 2024.
- On a quarterly basis, Income from Non-Controlling Interests rose 1515.91% year-over-year to $594.1 million in Q4 2024; TTM through Dec 2024 was $637.2 million, a N/A change from a year earlier, with the FY2024 full-year figure at $830.3 million, up 2078.71% from the prior year.
- Income from Non-Controlling Interests grew to $594.1 million in Q4 2024 per NYXH's latest filing, from -$42.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $594.1 million in Q4 2024 and bottomed at -$42.0 million in Q4 2023.
- The 4-year median for Income from Non-Controlling Interests is $42.5 million (2022), against an average of $159.3 million.
- Across the five-year window, Income from Non-Controlling Interests sank 242.74% in 2023 and soared 1515.91% in 2024, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $97.2 million in 2021, then sank by 112.59% to -$12.2 million in 2022, then sank by 242.74% to -$42.0 million in 2023, then surged by 1515.91% to $594.1 million in 2024.
- Per Business Quant, the three latest NYXH Income from Non-Controlling Interests figures stand at $594.1 million (Q4 2024), -$42.0 million (Q4 2023), and -$12.2 million (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -18.70 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | - |
| 10 | Nyxoah | 53.92 Mn | 100.91 Mn | 4.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 594.14 Mn |
| Dec 31, 2023 | -41.96 Mn |
| Dec 31, 2022 | -12.24 Mn |
| Dec 31, 2021 | 97.24 Mn |